Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02832557 · ClinicalTrials.gov registry record

A Salivary miRNA Diagnostic Test for Autism

A clinical trial, sponsored by State University of New York - Upstate Medical University.

Completed
Registry status
998
Enrollment target

NCT02832557: Completed study, sponsored by State University of New York - Upstate Medical University.

NCT02832557 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 998 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02832557 has completed, sponsored by State University of New York - Upstate Medical University.

COMPLETED
Registry status
998 participants
Enrollment target

Study Summary

The goal of this study is to validate a panel of miRNAs that distinguish children with autism spectrum disorder (ASD) from their non-ASD peers with a positive MCHAT-R. These biomarkers may allow earlier diagnosis of autism, allowing earlier service, and also help us to understand some of the changes in the brains of autistic children.

Primary Outcome

Measures of miRNA abundance in saliva

Interventions

  • OTHER Salivary collection
  • OTHER Vineland Adaptive Behavior Scale-III Assessment
  • OTHER Medical history questionaire
  • OTHER Autism Diagnostic Observation Schedule -2nd edition (ADOS-2)
  • OTHER Mullen Scales of Early Learning

Trial Details

FieldValue
Enrollment Target 998 participants
Start Date 2015-11-01
Est. Completion 2021-08-31
State University of New York - Upstate Medical University

113 total trials

What the finished NCT02832557 record still lists

NCT02832557 is an observational study that tracks outcomes without assigning an intervention. The registered 998 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 5 interventions - of which Salivary collection is the first listed.

NCT02832557 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02832557 about?

NCT02832557 is a clinical study titled "A Salivary miRNA Diagnostic Test for Autism". The goal of this study is to validate a panel of miRNAs that distinguish children with autism spectrum disorder (ASD) from their non-ASD peers with a positive MCHAT-R. These biomarkers may allow earlier diagnosis of autism, allowing earlier service, and also help us to understand some of the changes...

What is the current status of trial NCT02832557?

This trial is currently completed. The enrollment target is 998 participants. The study started on 2015-11-01. Estimated completion is 2021-08-31.

What interventions are being tested in trial NCT02832557?

The interventions under investigation include: Salivary collection (OTHER), Vineland Adaptive Behavior Scale-III Assessment (OTHER), Medical history questionaire (OTHER), Autism Diagnostic Observation Schedule -2nd edition (ADOS-2) (OTHER), Mullen Scales of Early Learning (OTHER).

Who is sponsoring clinical trial NCT02832557?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02986048 · 999 participants

    Proton Therapy Patient Registry

  • NCT04703244 · 999 participants

    Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02832557, the US trial registry maintained by the National Library of Medicine. NCT02832557 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.